Viibryd (Vilazodone) is a drug that was developed by Merck for the treatment of clinical depression. It was approved in the United States as an antidepressant medication in 2011. It functions as an atypical serotonergic antidepressant. Although some consider it to be similar to SSRIs, it differs in that it is unlikely to cause significant …
When a new antidepressant drug is released, everyone wants to be the first to try it. In most cases, people seem to always believe that newer will equal better in terms of depression relief. In most cases, when new drugs get approval to treat depression, they are backed by some heavy marketing, which further brainwashes …
The popularity of antidepressants has changed significantly over time. The first antidepressants called MAOIs were discovered in the 1950s and instantly became the most popular class. As newer tricyclic antidepressants emerged just a few years later, many of them were preferred over MAOIs because they carried less side effects and food interactions. The goal with …
Atypical antidepressants are unique from other classes of antidepressants based on pharmacological properties. These days, the most common antidepressants fit into one of a few categories: SSRIs/SNRIs, TCAs, and MAOIs. Respectively these are: selective-serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), tricyclics (TCAs), and monoamine oxidase inhibitors (MAOIs). SSRIs and SNRIs are considered the …
Approximately 1 out of 4 people that take antidepressants experience weight gain as a side effect. The weight gain may be minor, but over time, gaining a pound here and there all adds up. Many people have reported that there’s nothing they can really do to control the weight that they gain while on an …
Viibryd (Vilazodone) is a relatively popular new antidepressant that has been found effective for treating symptoms of major depression. Many people have had success with this antidepressant and tend to not experience as many of the other side effects associated with most SSRI’s such as: weight gain and sexual dysfunction. Although this drug may be …